Multiple sclerosis is a complex autoimmune disorder which characterized by demyelination and axonal loss in the central nervous system (CNS). Several evidences indicate that some new drugs and stem cell therapy have opened a new horizon for multiple sclerosis treatment, but current therapies are partially effective or not safe in the long term. Recently, herbal therapies represent a promising therapeutic approach for multiple sclerosis disease. Here, we consider the potential benefits of some herbal compounds on different aspects of multiple sclerosis disease. The medicinal plants and their derivatives; Ginkgo biloba, Zingiber officinale, Curcuma longa, Hypericum perforatum, Valeriana officinalis, Vaccinium macrocarpon, Nigella sativa,Piper...
ABSTRACTMultiple sclerosis (MS) is a chronic, disabling, recurrent demyelination of the central nerv...
BACKGROUND: Due to the considerable burden of multiple sclerosis (MS)-related symptoms and the need ...
Despite current therapeutic strategies for immunomodulation and relief of symptoms in multiple scler...
Introduction: Multiple sclerosis (MS) is an inflammatory chronic neurological disease, which affects...
Multiple sclerosis (MS) is the most common cause of neurologic disability in adults worldwide. Two m...
Recent findings highlight the emerging role of the endocannabinoid system in the control of symptoms...
Background: Multiple sclerosis (MS) is a chronic immune-mediated inflammatory disease of the central...
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system that is mainly mediat...
Multiple Sclerosis (MS) is an inflammatory disease of the central nervous system (CNS) which include...
The consistency, efficacy, and safety of cannabis-based medicines have been demonstrated in humans, ...
Multiple sclerosis is the most common inflammatory demyelinating disease of the central nervous syst...
Cannabinoids are compounds with pleiotropic properties that act on the cannabinoid receptors, CB1 an...
Multiple sclerosis (MS) is known as an autoimmune disease that damages the neurons in the central ne...
A large proportion of patients with multiple sclerosis (MS) have spasticity, which has a marked impa...
Purpose of review: Pharmaceutical cannabinoids such as nabiximols, nabilone and dronabinol, and plan...
ABSTRACTMultiple sclerosis (MS) is a chronic, disabling, recurrent demyelination of the central nerv...
BACKGROUND: Due to the considerable burden of multiple sclerosis (MS)-related symptoms and the need ...
Despite current therapeutic strategies for immunomodulation and relief of symptoms in multiple scler...
Introduction: Multiple sclerosis (MS) is an inflammatory chronic neurological disease, which affects...
Multiple sclerosis (MS) is the most common cause of neurologic disability in adults worldwide. Two m...
Recent findings highlight the emerging role of the endocannabinoid system in the control of symptoms...
Background: Multiple sclerosis (MS) is a chronic immune-mediated inflammatory disease of the central...
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system that is mainly mediat...
Multiple Sclerosis (MS) is an inflammatory disease of the central nervous system (CNS) which include...
The consistency, efficacy, and safety of cannabis-based medicines have been demonstrated in humans, ...
Multiple sclerosis is the most common inflammatory demyelinating disease of the central nervous syst...
Cannabinoids are compounds with pleiotropic properties that act on the cannabinoid receptors, CB1 an...
Multiple sclerosis (MS) is known as an autoimmune disease that damages the neurons in the central ne...
A large proportion of patients with multiple sclerosis (MS) have spasticity, which has a marked impa...
Purpose of review: Pharmaceutical cannabinoids such as nabiximols, nabilone and dronabinol, and plan...
ABSTRACTMultiple sclerosis (MS) is a chronic, disabling, recurrent demyelination of the central nerv...
BACKGROUND: Due to the considerable burden of multiple sclerosis (MS)-related symptoms and the need ...
Despite current therapeutic strategies for immunomodulation and relief of symptoms in multiple scler...